{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/hepatitis-b/","result":{"pageContext":{"chapter":{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B","depth":2,"htmlHeader":"<!-- begin field b6463c7b-5ce7-4f23-a05a-9217dd7554fa --><h2>Scenario: Hepatitis B</h2><!-- end field b6463c7b-5ce7-4f23-a05a-9217dd7554fa -->","summary":"Covers advice for people travelling to areas endemic with hepatitis B.","htmlStringContent":"<!-- begin item 8b6a6847-8b08-4456-aa3b-39ccef14bb85 --><!-- begin field 9af7e09a-2dab-45aa-b7e9-acd900ab5242 --><p>From birth onwards.</p><!-- end field 9af7e09a-2dab-45aa-b7e9-acd900ab5242 --><!-- end item 8b6a6847-8b08-4456-aa3b-39ccef14bb85 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"628fe012-fe1f-54dc-8b49-702fd5c304e0","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field 71f0a5a0-56e0-4878-b682-d3ba21252deb --><h3>Indications for vaccine</h3><!-- end field 71f0a5a0-56e0-4878-b682-d3ba21252deb -->","summary":null,"htmlStringContent":"<!-- begin item 0e75efec-2a95-410c-97eb-557247c610be --><!-- begin field db077f31-adc4-41af-8bb5-08569543008e --><ul><li><strong>Hepatitis B vaccine is indicated for t</strong><strong>ravellers to areas of high or intermediate prevalence who are at risk of contracting hepatitis B including:</strong> <ul><li>People participating in contact sports.</li><li>People undertaking relief aid work.</li><li>People who inject drugs.</li><li>People engaging in unsafe sexual activity. </li><li>People who plan to remain in areas of high or intermediate prevalence for long periods.</li><li>People at risk of requiring medical or dental treatment in countries where unsafe therapeutic injections (i.e. the re-use of contaminated needles and syringes without sterilization) occurs or where donated blood is not screened, including:<ul><li>Children and others who may require medical care while travelling to visit friends or relatives in high- or moderate-endemicity countries.</li><li>People with chronic medical conditions who may require hospitalization while overseas.</li><li>Those travelling for medical care.</li></ul></li></ul></li><li>For other specific indications for hepatitis B immunization, see <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\" data-hyperlink-id=\"35802091-5f30-4dc0-a791-a93100b84fdf\">The Green Book</a>.</li></ul><!-- end field db077f31-adc4-41af-8bb5-08569543008e --><!-- end item 0e75efec-2a95-410c-97eb-557247c610be -->","subChapters":[{"id":"c579e9fb-e21c-5e1c-ae15-3b6dae588fa5","slug":"basis-for-recommendation-f09","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 837e403f-04c4-4e7d-8152-5ecf483adade --><h4>Basis for recommendation</h4><!-- end field 837e403f-04c4-4e7d-8152-5ecf483adade -->","summary":null,"htmlStringContent":"<!-- begin item f0902f3f-5ab4-48f8-b598-b910cf310c27 --><!-- begin field 62cfe4f2-2c99-46ba-bcdc-5adc055d58ea --><p>The recommendations on indications for hepatitis B vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book)</em> <em>Chapter 18: Hepatitis B</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>].</p><!-- end field 62cfe4f2-2c99-46ba-bcdc-5adc055d58ea --><!-- end item f0902f3f-5ab4-48f8-b598-b910cf310c27 -->","subChapters":[]}]},{"id":"859a8640-6f03-5b84-9f7c-4aac53cd0786","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field c696212c-feea-4833-aec2-a05d3a9445ad --><h3>Available vaccines and vaccination schedule</h3><!-- end field c696212c-feea-4833-aec2-a05d3a9445ad -->","summary":null,"htmlStringContent":"<!-- begin item 4a93c703-29f3-4d48-80a8-24b0e29ffb24 --><!-- begin field c218473b-41f7-4ea7-bc6a-2b1394d559e0 --><ul><li><strong>There are several hepatitis B vaccines licensed for use in the UK, all of which are inactivated. These are:</strong><ul><li>Engerix B<sup>® </sup>20 micrograms/1 mL (licensed for use from birth to 16 years of age).</li><li>Engerix B<sup>® </sup>10 micrograms/1 mL (licensed for use from 16 years of age).</li><li>HBvaxPRO<sup>®</sup> 10 micrograms (licensed for use from 16 years of age).</li><li>HBvaxPRO<sup>®</sup> 5 micrograms (licensed for use from birth to 16 years of age).</li><li>HBvaxPRO<sup>®</sup> 40 micrograms (indicated for adult dialysis and predialysis patients).</li><li>Fendrix<sup>®</sup> (indicated for people who have renal insufficiency).</li></ul></li><li>Combined hepatitis A and B vaccines are also available (Ambirix<sup>®</sup>,<sup> </sup>Twinrix Adult<sup>®</sup>, and Twinrix Paediatric<sup>®</sup>).</li><li><strong>There are several vaccination schedules recommended for Hepatitis B.</strong><ul><li>Vaccination at 0, 1, and 2 months is used for most travellers.</li><li>In exceptional circumstances (for example if the traveller is departing within 1 month) the initial doses can be given at 0, 7, and 21 days (aged 16 years and older). A fourth dose administered 12 months after the first dose is required for ongoing protection.</li></ul></li><li>For more information, please see the chapter on Hepatitis B immunization in <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\" data-hyperlink-id=\"ecf23331-3d0b-4a4b-85f0-a931009ed39f\">The Green Book</a>.</li></ul><!-- end field c218473b-41f7-4ea7-bc6a-2b1394d559e0 --><!-- end item 4a93c703-29f3-4d48-80a8-24b0e29ffb24 -->","subChapters":[{"id":"0e25b925-77c0-5003-be08-78308909c55d","slug":"basis-for-recommendation-e97","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 008f3be5-1b6e-4801-a598-91681508ae13 --><h4>Basis for recommendation</h4><!-- end field 008f3be5-1b6e-4801-a598-91681508ae13 -->","summary":null,"htmlStringContent":"<!-- begin item e97b0e54-30c7-41d5-a7ef-66e7fac30152 --><!-- begin field 183689f1-2d97-4a8b-ad73-ca88e0e4b8f6 --><p>The information on available types of hepatitis B vaccine and vaccination schedules is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 18: Hepatitis B </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>].</p><!-- end field 183689f1-2d97-4a8b-ad73-ca88e0e4b8f6 --><!-- end item e97b0e54-30c7-41d5-a7ef-66e7fac30152 -->","subChapters":[]}]},{"id":"fdd05de0-4fb0-515e-be21-068754721006","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 80be53de-023b-4608-a4c4-f700192b4954 --><h3>Contraindications to vaccine</h3><!-- end field 80be53de-023b-4608-a4c4-f700192b4954 -->","summary":null,"htmlStringContent":"<!-- begin item fdf88dfd-2052-418d-82ff-9259819f16cd --><!-- begin field e320dec5-4b60-4aa5-810c-f0f0cfc4d788 --><ul><li><strong>Do not give hepatitis B vaccine if the person has:</strong><ul><li>Had a confirmed anaphylactic reaction to a previous dose of hepatitis B vaccine.</li><li>Had a confirmed anaphylactic reaction to any component of hepatitis B vaccine.</li></ul></li><li><strong>Postpone hepatitis B vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>Hepatitis B vaccine should not be withheld from a pregnant woman if she is in a high-risk group.</strong> There is no evidence of risk from vaccinating pregnant women or those who are breastfeeding with inactivated virus, bacterial vaccines, or toxoids.</li></ul><!-- end field e320dec5-4b60-4aa5-810c-f0f0cfc4d788 --><!-- end item fdf88dfd-2052-418d-82ff-9259819f16cd -->","subChapters":[{"id":"a4a40ec6-3d73-58ab-ac4b-212d616cdb15","slug":"basis-for-recommendation-9c4","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field cff6ca1c-4471-4bd3-b1a1-0ab92290f8f9 --><h4>Basis for recommendation</h4><!-- end field cff6ca1c-4471-4bd3-b1a1-0ab92290f8f9 -->","summary":null,"htmlStringContent":"<!-- begin item 9c4cc135-aef7-4275-8dd3-975e333ebf8e --><!-- begin field b7c24943-3b26-4c51-8f74-64e28274c1a6 --><p>The information on contraindications to hepatitis B vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 18: Hepatitis B</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>] and <em>Chapter 6: Contraindications and special considerations </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><!-- end field b7c24943-3b26-4c51-8f74-64e28274c1a6 --><!-- end item 9c4cc135-aef7-4275-8dd3-975e333ebf8e -->","subChapters":[]}]},{"id":"679e501d-22a6-583e-9c91-4e408c383531","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field dafc6b6a-6021-4d63-b5f0-ce58876cbd9d --><h3>Adverse effects</h3><!-- end field dafc6b6a-6021-4d63-b5f0-ce58876cbd9d -->","summary":null,"htmlStringContent":"<!-- begin item a54e9422-1c70-4420-8af7-060ed171b47f --><!-- begin field d7badf15-bf28-4f36-af1a-1ddbfe3bcb4e --><ul><li>Hepatitis B vaccine is generally well tolerated, and the most common adverse reactions are soreness and redness at the injection site.</li><li>Other reactions that have been reported include fever, rash, malaise, an influenza-like syndrome, arthritis, arthralgia, myalgia, and abnormal liver function tests.</li><li>Serious suspected neurological reactions such as Guillain–Barré syndrome and demyelinating disease have been reported, although these have been very rare and a causal relationship with hepatitis B vaccine has not been established.</li></ul><!-- end field d7badf15-bf28-4f36-af1a-1ddbfe3bcb4e --><!-- end item a54e9422-1c70-4420-8af7-060ed171b47f -->","subChapters":[{"id":"ea455b37-53fc-5f49-87b3-feb4086258e6","slug":"basis-for-recommendation-91c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 181701b2-149e-41c5-ac90-2f18077ee176 --><h4>Basis for recommendation</h4><!-- end field 181701b2-149e-41c5-ac90-2f18077ee176 -->","summary":null,"htmlStringContent":"<!-- begin item 91cfbc8a-40fc-4ef4-acb4-4052c3f88369 --><!-- begin field 63bc38f1-d704-4bbd-a6cb-6727aaeedf77 --><p>The information on adverse reactions to hepatitis B vaccine is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 18: Hepatitis B </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>].</p><!-- end field 63bc38f1-d704-4bbd-a6cb-6727aaeedf77 --><!-- end item 91cfbc8a-40fc-4ef4-acb4-4052c3f88369 -->","subChapters":[]}]},{"id":"4cf751dc-2abb-5c84-b131-f4bd8c7b6919","slug":"how-to-administer-the-hepatitis-b-vaccine","fullItemName":"How to administer the hepatitis B vaccine","depth":3,"htmlHeader":"<!-- begin field 8184e398-bf3c-4153-be99-298db84229af --><h3>How to administer the hepatitis B vaccine</h3><!-- end field 8184e398-bf3c-4153-be99-298db84229af -->","summary":null,"htmlStringContent":"<!-- begin item 6241a79c-be71-47b1-a02c-0a4498850725 --><!-- begin field f35ac27e-223e-45de-873c-07b21ab9e4d7 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/hepatitis-b/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/hepatitis-b/#adverse-effects\">adverse reactions</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li></ul><ul><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>Hepatitis B vaccine is usually given by intramuscular (IM) injection,</strong> into the upper arm in children and adults, or the anterolateral thigh in infants under 1 year of age. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Hepatitis B vaccine can be given at the same time as other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field f35ac27e-223e-45de-873c-07b21ab9e4d7 --><!-- end item 6241a79c-be71-47b1-a02c-0a4498850725 -->","subChapters":[{"id":"551a1f4f-fe23-5f72-86be-44be4df60ba3","slug":"basis-for-recommendation-1b4","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field b4583fa7-6277-4c44-b8ca-a6fbbcf4638d --><h4>Basis for recommendation</h4><!-- end field b4583fa7-6277-4c44-b8ca-a6fbbcf4638d -->","summary":null,"htmlStringContent":"<!-- begin item 1b4c387a-7076-46ff-8f1f-76c14cddd02d --><!-- begin field 3a2dd2a4-143a-4007-842d-4e65f0b518d3 --><p>The recommendations on how to administer hepatitis B vaccines are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease</em> <em>(The Green Book) Chapter 18: Hepatitis B</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>], <em>Chapter 2: Consent</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><div><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul></div><!-- end field 3a2dd2a4-143a-4007-842d-4e65f0b518d3 --><!-- end item 1b4c387a-7076-46ff-8f1f-76c14cddd02d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}